Skip to main content

COVAXIN: Do you know about India's first indigenous vaccine for COVID-19?

India's first indigenous vaccine for COVID-19: In a piece of good news, India's first coronavirus vaccine-- COVAXIN-- developed by Hyderabad-based Bharat Biotech has got green signal from the Drug Controller General of India (DCGI) to conduct human clinical trials.

Amid the surging COVID-19 cases around the world, in a piece of good news, India's first coronavirus vaccine-- COVAXIN-- developed by Hyderabad-based Bharat Biotech has got green signal from the Drug Controller General of India (DCGI) to start with human clinical trials. 
The vaccine is made in collaboration with ICMR (Indian Council of Medical Research) and NIV (National Institute of Virology). 
The SARS-CoV-2 strain was isolated in NIV, Pune and was transferred to Bharat Biotech. The inactivated COVID-19 vaccine, developed at Bharat Biotech’s BSL-3 (Bio-Safety Level 3) high containment facility located in the Genome Valley, Hyderabad, has got approval to begin its Phase I and Phase II human clinical trials. 
The permission was granted by The DGCI, CDSCO (Central Drugs Standard Control Organisation), and Ministry of Health and Family Welfare after the company submitted the results of pre-clinical studies related to safety and immune response.  
These clinical trials are designed to test whether the vaccines are safe or not. The effectiveness of the vaccine will be tested in the next phases. Volunteers across India will be immunised with 'Made in India' COVID-19 vaccine in July 2020. However, the number of people and the date has not been mentioned yet. 
Prime Minister Modi in 'Man ki Baat' stated that work is being done in the labs on Coronavirus vaccine and the world is keenly observing India and the country is hopeful too. 
Bharat Biotech's Chairman and MD, Dr Krishna Ella stated that the company is proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine. The company's Research and Development and  Manufacturing teams have worked tirelessly to deploy the proprietary technologies towards this platform. 
Bharat Biotech has a good track record when it comes to developing Vero cell culture platform technologies and has given successful vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika. 
Apart from this, 5 other Indian firms are working on COVID-19 vaccine. Around 120 vaccine programs in the world are underway. Pharma companies, researchers and scientists around the globe are working day and night to develop COVID-19 vaccine.  

Comments

Popular posts from this blog

GK Questions and Answers: Geographical Indications (GI) Tags in India

A geographical indication (GI) is a name or sign used on certain products like agriculture, machinery products, and sweets, etc. which relates to a specific geographical location or origin (e.g., region, or country or a town). We have published a set of 10 important GK questions and answers on the Geographical Indications (GI) Tags in India. This set of 10 important GK questions and answers on the Geographical Indications (GI) Tags in India is very important for exams like UPSC/PSC/SSC/CDS etc. 1. Which was the first Indian product to get the geographical indication tag? (a).Aranmula Kannadi (b).Darjeeling Tea (c).Katarni Rice (d).Madhubani Paintings Answer:- b Explanation:-  Darjeeling Tea was the first Indian product to get the geographical indication tag in 2004.  2. How many products got GI tags till now? (a) 361 (b) 729 (c) 624 (d) None of the above Answer:- a Explanation:-  Till date 361 products have been issued GI tag. The latest recipient of the GI ta...

What is sero-surveillance? How will it help in tracking COVID-19 infection?

Sero-surveillance: The Indian Council of Medical Research, ICMR has issued an advisory to all the states of India to conduct serosurvey to monitor the Coronavirus pandemic. The Indian Council of Medical Research, ICMR has issued an advisory to all the states of India to conduct serosurvey to monitor the Coronavirus pandemic. The advisory further states that these tests can be carried out on frontline workers, medical professionals, vendors, police personnel, the staff of restaurants and grocery shops, etc. In addition to these, individuals residing in the containment zones and patients with chronic illness tuberculosis, HIV, etc. will also be covered.  The survey will also be conducted on asymptomatic individuals and the previously infected COVID-19 hit patients that have now recovered. The survey will be conducted with the help of the ELISA test kit.  What is sero-surveillance? In serosurvey or sero-surveillance, testing of blood serum of a group of individuals is c...

List of Products India imports from China

China is the source of around 14% of total Indian imports. Indian import from China includes; electrical machinery, cell phones, heavy machinery, telecom, power, plastic toys and critical pharma ingredients, furniture, pharma, fertiliser, food, and textiles, etc. India has imported goods worth $62.4 billion from China during April 2019-February 2020 period. As we know that the USA is the largest trading partner of India and China is in the second position. The basic difference between the India-USA and India-China trade is that India has a trade surplus of US& 16 billion with the USA while trade deficit of US& 53 billion with China in 2018-19. China is the source of nearly 13.7% of India’s imports  across sectors such as chemicals, automotive components, consumer electronics, and pharmaceuticals. Indian medical industry is heavily dependent on Chinese ingredients to manufacture medical instruments and medicine in India. Sudarshan Jain, President of the Indian Phar...